beta

PTIE

Pain Therapeutics Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Pain Therapeutics Inc is a biopharmaceutical company that develops novel drugs. The Company has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.

Market Cap: 49.1 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.paintrials.com

Shares Outstanding: 6.6 Million

Float: 933 Thousand

Dividend: 0.0 (0.0%)

Beta: 3.026915

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1314 trading days

From: 2014-06-26 To: 2019-03-27

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-05-10 7.0 1.0 7.0
Data provided by IEX Cloud